Organ infiltration in patients with progressive CLL
Patient . | Organ . | Asymptomatic disease . | Active disease . |
---|---|---|---|
#1 | Spleen | (vi) − | − |
LN | − | + | |
#2 | Spleen | − | + |
LN | − | + | |
#3 | Spleen | − | + |
LN | − | + | |
#4 | Spleen | − | + |
LN | + | + | |
#5 | Spleen | − | + |
LN | + | + |
Patient . | Organ . | Asymptomatic disease . | Active disease . |
---|---|---|---|
#1 | Spleen | (vi) − | − |
LN | − | + | |
#2 | Spleen | − | + |
LN | − | + | |
#3 | Spleen | − | + |
LN | − | + | |
#4 | Spleen | − | + |
LN | + | + | |
#5 | Spleen | − | + |
LN | + | + |
Analyses were performed on 5 CLL patients with asymptomatic disease (asymptomatic) and at a later stage (active) when disease progressed sufficiently to require treatment. Organ infiltration was assessed as reported previously.6
−, undetectable organ infiltration; +, organ infiltration.